IMAGINE

WILL TRANSFORM THE MANAGEMENT OF IBD AND IBS AND ASSOCIATED MENTAL HEALTH ISSUES WITH THESE DISORDERS

IMAGINE

AIMS TO FIND NEW THERAPIES FOR THE TREATMENT OF IBS, IBD, AND ASSOCIATED PSYCHIATRIC DISORDERS

IMAGINE

IS THE FUTURE OF HEALTH

Canada has one of the highest rates of IBS and IBD disorders in the world.

 

People living with GI disorders have higher rates of anxiety and depression compared to the general population and patients with anxiety and depression are reported to have more GI symptoms.

Learn more

IMAGINE will be developing innovative therapies and novel probiotics for Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD). We’ve been patient-driven in setting priorities for this work. We believe IBD and IBS are caused by an immune response to the disturbance in the gut’s microbiome, and we know diet plays a key role in shaping the gut microbiome.

Dr. Paul Moayyedi

Principal Investigator, IMAGINE